---
title: "Trident Lifeline Ltd (543616) — Share Price, Financials & Analysis"
symbol: "543616"
company: "Trident Lifeline Ltd"
canonical: "https://tapetide.com/stocks/543616"
isin: "INE0MKA01014"
nse_symbol: "TRIDENTLIFELINELTD"
bse_code: "543616"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 355.5
generated_at: "2026-09-13T18:26:52.998Z"
---

# Trident Lifeline Ltd (543616)

Canonical page: https://tapetide.com/stocks/543616

## Company

- **NSE Symbol:** TRIDENTLIFELINELTD
- **BSE Code:** 543616
- **ISIN:** INE0MKA01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2022-10-10
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** tridentlifeline.com

## About

Incorporated in 2014, Trident Lifeline Ltd manufactures and sells pharmaceuticals 
products[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:46:01.744238Z.

- **Market Cap:** ₹355.5 Cr
- **Classification:** SME
- **P/E (reported):** 16.5
- **EPS (TTM):** ₹17.73
- **EPS (reported):** ₹5.94
- **Book Value:** ₹84.5
- **Price to Book:** 3.52
- **Dividend Yield:** 0%
- **ROE:** 15.07%
- **ROCE:** 17.18%
- **Debt to Equity:** 0.73
- **Revenue (yearly):** ₹129.02 Cr
- **Net Income:** ₹19.23 Cr
- **EBITDA:** ₹28.11 Cr
- **52-Week High:** ₹328
- **52-Week Low:** ₹229.95
- **RSI (14):** 68.02

## Tapetide Score

- **Score:** 50 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Flat
- **Percentile:** 47.7 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 44.18 | 9% |
| growth | 96.75 | 9% |
| momentum | 58.3 | 12% |
| ownership | 32.03 | 24% |
| quality | 48.08 | 22% |
| valuation | 49.51 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Company has high debtors of 208 days.
- Promoter holding has decreased over last 3 years: -7.45%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -559.19% | 46.11% | -69.54% |
| ebitda margin growth | -27.78% | -16.2% | -7.55% | 37.36% |
| net income growth | -25% | 83.14% | 47% | 393.08% |
| revenue growth | -33.53% | 35.53% | 60% | 41.93% |
| roce | -34.36% | 23.42% | 24.4% | 23.64% |
| roe | -25.44% | 36.88% | 12.95% | 17.92% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 8.64 | 7.09 | 19.13 | 13.15 | 15.45 | 11.83 | 34.01 | 23.61 | 31.34 | 25.71 | 49.95 | 33.72 |
| Expenses | 6.88 | 5.66 | 16.77 | 10.66 | 11.4 | 7.76 | 25.47 | 18.44 | 24.48 | 20.62 | 38.96 | 25.2 |
| Operating Profit | 1.76 | 1.43 | 2.36 | 2.49 | 4.05 | 4.07 | 8.54 | 5.17 | 6.86 | 5.09 | 10.99 | 8.52 |
| OPM % | 20.37 | 20.17 | 12.34 | 18.94 | 26.21 | 34.4 | 25.11 | 21.9 | 21.89 | 19.8 | 22 | 25.27 |
| Other Income | 0.33 | 0.25 | 1.47 | 1.15 | 0.54 | 0.56 | 1.87 | 1.35 | 1.67 | 4.63 | 1.62 | 0.57 |
| Interest | 0.1 | 0.15 | 0.37 | 0.49 | 0.5 | 0.55 | 1.55 | 1.13 | 0.99 | 1.24 | 0.77 | 0.86 |
| Depreciation | 0.13 | 0.19 | 0.39 | 0.54 | 0.16 | 0.61 | 2.74 | 1.46 | 0.91 | 2.46 | 1.23 | 1.62 |
| Profit before tax | 1.86 | 1.34 | 3.07 | 2.61 | 3.93 | 3.47 | 6.12 | 3.93 | 6.63 | 6.02 | 10.61 | 6.61 |
| Tax % | 24.73 | 21.64 | 46.91 | 38.7 | 28.5 | 26.51 | -0.33 | 29.26 | 23.23 | 22.76 | 36 | 23.3 |
| Net Profit | 1.4 | 1.05 | 1.63 | 1.6 | 2.8 | 2.56 | 6.14 | 2.78 | 5.09 | 4.64 | 6.8 | 5.07 |
| EPS in Rs | 1.22 | 0.94 | 1.77 | 1.99 | 2.69 | 2.43 | 6.15 | 2.66 | 4.27 | 3.6 | 5.64 | 4.22 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 22 | 32 | 45 | 87 | 129 | 141 |
| Expenses | 19 | 25 | 36 | 72 | 101 | 109 |
| Operating Profit | 3 | 6 | 8 | 15 | 28 | 31 |
| OPM % | 12 | 20 | 18 | 17 | 22 | 22 |
| Other Income | 1 | 1 | 2 | 8 | 9 | 8 |
| Interest | 0 | 0 | 1 | 4 | 4 | 4 |
| Depreciation | 0 | 0 | 1 | 5 | 6 | 6 |
| Profit before tax | 3 | 7 | 9 | 14 | 27 | 30 |
| Tax % | -32 | 8 | 32 | 23 | 29 | — |
| Net Profit | 4 | 6 | 6 | 10 | 19 | 22 |
| EPS in Rs | 4.94 | 5.24 | 5.51 | 10.22 | 15.96 | 17.73 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 8 | 12 | 12 | 12 | 12 |
| Reserves | -3 | 34 | 41 | 53 | 88 |
| Borrowings | 2 | 8 | 18 | 54 | 73 |
| Other Liabilities | 7 | 9 | 16 | 37 | 63 |
| Total Liabilities | 14 | 63 | 87 | 156 | 237 |
| Fixed Assets | 1 | 3 | 21 | 44 | 61 |
| CWIP | 0 | 5 | 4 | 2 | 18 |
| Investments | 0 | 3 | 4 | 11 | 8 |
| Other Assets | 12 | 51 | 58 | 99 | 150 |
| Total Assets | 14 | 63 | 87 | 156 | 237 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | -19 | 2 | -10 | 5 |
| Cash from Investing Activity | 0 | -10 | -20 | -14 | -37 |
| Cash from Financing Activity | 1 | 42 | 11 | 20 | 34 |
| Net Cash Flow | 0 | 14 | -7 | -4 | 2 |
| Free Cash Flow | -1 | -26 | -16 | -21 | -29 |
| CFO/OP | -8 | -294 | 56 | -38 | 45 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 83 | 139 | 110 | 116 | 208 |
| Inventory Days | 95 | 129 | 156 | 226 | 174 |
| Days Payable | 134 | 87 | 94 | 119 | 183 |
| Cash Conversion Cycle | 44 | 182 | 173 | 224 | 199 |
| Working Capital Days | 49 | 275 | 205 | 144 | 134 |
| ROCE % | — | 23 | 15 | 18 | 21 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 70.04% | 70.04% | 67.48% | 65.51% | 62.99% | 62.99% | 63.04% | 63.04% | 63.11% | 64.11% | 62.85% | 62.59% |
| FIIs | 4.64% | 4.64% | 6.02% | 6.02% | 6.09% | 6.09% | 6.62% | 7.21% | 7.71% | 7.04% | 7.24% | 5.25% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0.09% | 0.39% | 0.41% | 0.35% | 0.27% | 0.26% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 14.82% | 14.43% | 16.39% | 18.37% | 19.4% | 18.9% | 18.26% | 17.9% | 17.63% | 17.29% | 18.67% | 20.58% |
| Others | 10.5% | 10.88% | 10.1% | 10.1% | 11.52% | 12.02% | 11.99% | 11.45% | 11.14% | 11.22% | 10.97% | 11.31% |
| No. of Shareholders | 439 | 481 | 500 | 502 | 507 | 523 | 534 | 549 | 554 | 549 | 607 | 709 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 3 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 285.93 | Buy |
| EMA (10) | 288.81 | Buy |
| SMA (20) | 281.06 | Buy |
| EMA (20) | 281.79 | Buy |
| SMA (50) | 269.14 | Buy |
| EMA (50) | 271.9 | Buy |
| SMA (100) | 260.65 | Buy |
| EMA (100) | 267.34 | Buy |
| SMA (200) | 271.14 | Buy |
| EMA (200) | 268.41 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 70.66 | Sell |
| MACD (12,26,9) | 8.06 | Buy |
| Stochastic (14,3,3) | 76.6 | Neutral |
| ADX (14) | 34.76 | Buy |
| Williams %R (14) | -12.81 | Sell |
| ATR (14) | 10.4 | High Volatility |
| ROC (12) | 11.01 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 53.92 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Disclosure Under Regulation 30 Of SEBI (LODR)- Intimation Of Award](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ab21143-9978-4c20-8db6-36797dd0ea91.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89fa93e0-2231-459e-a524-9ebac7372720.pdf) |
| 2026-09-04 | [Revision Of Book Closure And Cut-Off Date For The 13Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c5f2ea8-f256-4c55-b944-68c29ec4878c.pdf) |
| 2026-09-04 | [Notice Of 13Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72bebaba-a543-437e-b51b-702bcd9a5eb4.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47709929-2c08-4640-9707-baf3090fc407.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cf5abd4-1e86-4234-ab18-05790b1b7a93.pdf) |
| 2026-08-31 | [Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015-Intimation Of Award](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef49ccfc-de31-4123-a180-cb26db7b7be1.pdf) |
| 2026-08-31 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On August 31 2026 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eeb0bc8f-a34a-4ddf-bf70-bb3b9115a1fc.pdf) |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Allotment](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c635602b-b0b0-4405-8c48-486762906bed.pdf) |
| 2026-08-26 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 26.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=560a5304-8025-4398-9498-d41268b548d9.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46e1e196-d6c8-4477-8377-349f5331b892.pdf) |
| 2026-05-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfcf2c51-070e-4e47-952c-b5ac110e52db.pdf) |
| 2026-01-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73d40b37-7a9e-4c97-b624-796b66adf8f4.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=152dba81-8b30-45ec-9690-531439aae0cc.pdf) |
| 2025-07-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b48cd6c0-8ef3-4846-8e4f-9aa51e3ef561.pdf) |
| 2024-10-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a753a2e-a545-4872-9c79-fe7e983d7b2f.pdf) |
| 2024-07-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4037c9a-5ed2-4249-a5e2-e46103904a5a.pdf) |
| 2024-05-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d2259f0-fa8a-4845-b815-950997f4728c.pdf) |
| 2023-11-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d52157fd-7370-4c09-bfae-d7ebed34ec19.pdf) |
| 2023-07-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9a66396-c1db-451e-83f7-2dc7f2abfc49.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-29 | [Result- Financial Result For Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=996945de-96ab-4c60-aa8d-e621202ebb37.pdf) |
| 2026-05-07 | [Result- Financial Result For Half Year And Year Ended On 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83e33fa1-3248-4f51-9948-3ed0cca575dc.pdf) |
| 2026-01-17 | [Result- Financial Results For The Quarter And Nine Months Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbbab78d-678a-41bd-bedc-9e9f47598a37.pdf) |
| 2025-11-14 | [Revised Unaudited Financial Results For The Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f87dde6e-89ae-4793-853f-f6abe1ac8eb3.pdf) |
| 2025-11-11 | [Result-Financial Result For The Half Year Ended 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc9e8c31-e0a3-44b8-a97b-3f2207832013.pdf) |
| 2025-07-28 | [Board Meeting Outcome for For Financial Result For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13769c73-b9ce-4430-ab66-c76265574f9e.pdf) |
| 2025-07-28 | [Financial Result For The Quarter Ended June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b96bfdb0-a379-46d4-9f06-dffd49afb73c.pdf) |
| 2025-04-28 | [Result-Financial Result For The Half Year And Year Ended On March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bde5ed4b-40f5-491a-8708-f841a9b986eb.pdf) |
| 2025-01-22 | [Result-Financial Result For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d17217c0-e73b-4b9d-950a-ec186d17dc42.pdf) |
| 2024-10-19 | [Result-Financial Result For The Half Year Ended On September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fbae326-14c5-4d3b-b715-8c3b84ca3425.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/71ae92f1-24cd-407d-a763-22c738b758db.pdf) |
| 7 May - Trident Lifeline approved FY26 audited standalone and consolidated results; appointed DAC & Co. as internal auditor for FY27. | [Board Meeting Outcome for Outcome Of Board Meeting Held On May 07, 2026 7 May - Trident Lifeline approved FY26 audited standalone and consolidated results; appointed DAC & Co. as internal auditor for FY27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0d1aa17d-028e-4da9-8b45-3b24b750249b.pdf) |
| 7 May - Board approved audited FY26 standalone and consolidated results on 7 May 2026; appointed DAC & Co. internal auditor. | [Appointment Of Internal Auditor 7 May - Board approved audited FY26 standalone and consolidated results on 7 May 2026; appointed DAC & Co. internal auditor.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0bbb6fac-c63d-445d-a76e-7916e23e1bd3.pdf) |
| 4 May - Board meeting rescheduled to 7 May 2026 for audited standalone and consolidated results; trading window remains closed. | [Update on board meeting 4 May - Board meeting rescheduled to 7 May 2026 for audited standalone and consolidated results; trading window remains closed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/89e4c516-9f21-4426-a500-e2af330e26d0.pdf) |
| 30 Apr - Trident Lifeline confirms it is not a Large Corporate as on 31.03.2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Trident Lifeline confirms it is not a Large Corporate as on 31.03.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ce03da1-a778-462c-82a7-532f3da196bb.pdf) |
| 30 Apr - Trident Lifeline confirms it is not a Large Corporate as on 31.03.2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Trident Lifeline confirms it is not a Large Corporate as on 31.03.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6ce03da1-a778-462c-82a7-532f3da196bb.pdf) |
| 3 Mar - Trident Mediquip private placement; Trident Lifeline stake falls 60.04%→57.34%. | [Announcement under Regulation 30 (LODR)-Acquisition 3 Mar - Trident Mediquip private placement; Trident Lifeline stake falls 60.04%→57.34%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/114e1cde-7b6b-4f57-9648-03f3d9c48443.pdf) |
| 3 Mar - RateGain unites Adara and Sojern under Sojern brand, March 3, 2026, creating largest travel-intent data source. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 3 Mar - RateGain unites Adara and Sojern under Sojern brand, March 3, 2026, creating largest travel-intent data source.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff5e983c-b94e-41da-b77a-780097963668.pdf) |
| 2d - In accordance with Regulation 47 and other applicable provisions of SEBI (LODR) Regulations, we hereby enclose copies of newspaper advertisement published on May 09, 2026 … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 2d - In accordance with Regulation 47 and other applicable provisions of SEBI (LODR) Regulations, we hereby enclose copies of newspaper advertisement published on May 09, 2026 …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7b060059-98e8-4586-bd52-19f251a3ddee.pdf) |
| 2d - Earnings Presentation for the half year and year ended 31st March, 2026 (H2 & FY26). | [Announcement under Regulation 30 (LODR)-Investor Presentation 2d - Earnings Presentation for the half year and year ended 31st March, 2026 (H2 & FY26).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cfcf2c51-070e-4e47-952c-b5ac110e52db.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2ac9758c-6280-4e9b-94eb-18965b828334.pdf) |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e6daee7b-288b-46ad-840b-4b8b500b88bb.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a753a2e-a545-4872-9c79-fe7e983d7b2f.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/152dba81-8b30-45ec-9690-531439aae0cc.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d52157fd-7370-4c09-bfae-d7ebed34ec19.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4120a342-a48f-45e2-9f67-fa8ed52b11c7.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cfcf2c51-070e-4e47-952c-b5ac110e52db.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3d2259f0-fa8a-4845-b815-950997f4728c.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/81d70aef-4a30-4675-9df0-5aeb7dbb1037.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/50d64eab-b2ba-49fe-bc81-f62601d0ad50.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from web | [Financial Year 2024 from web](https://nsearchives.nseindia.com/annual_reports/AR_25090_RATEGAIN_2023_2024_23082024125211.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93413e0f-a120-48e1-ab6c-a4c3224f2983.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/82c78f7b-49e5-43b5-ac32-5e8c46477379.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6725a386-9be6-4fd2-952f-aede7a622b13.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1b1927f-f19e-4c12-ab2d-ca11012481bc.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2831a88a-7f26-477a-99a0-d873dd7a0e92.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543417/74832543417.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:52.998Z.